Does dialectical behaviour therapy (DBT) reduce hospital utilisation by self-harming participants?
Not Applicable
Completed
- Conditions
- Deliberate self-harm / Personality DisordersMental and Behavioural Disorders
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
1. Aged 18 years and over, men and women.
2. Referrals to the Intensive Psychological Therapies Service (IPTS).
3. History of DSH for at least a year, with a minimum of at least 6 self-harming incidents in the last year (Kreitman, 1977).
Exclusion Criteria
1. On-going in-patient care.
2. Drug or alcohol dependence (DSM-IV, 1994).
3. A psychotic disorder (DSM-IV, 1994).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The frequency and duration of all inpatient admissions, and frequency of A&E admissions, were measured for 6 monthly periods for the 6 months before the study, the study period, and up to 24-months after the intervention. This was collected by using the Dorset HealthCare Trust Participant Administration System.
- Secondary Outcome Measures
Name Time Method <br> 1. Millon Clinical Multi-axial Inventory (MCMI-III). This assessed if a client had any of 10 Clinical Syndromes and 14 Personality Patterns, by answering true or false statement questions.<br> 2. Clinical Outcomes in Routine Evaluation (CORE). This assessed a clients? level of risk to themselves and others, and an overall global distress score, using a 5-point likert scale.<br> 3. Dissociation Questionnaire (DisQ). This measured the amount of dissociation felt by a client, using a 5-point likert scale.<br> 4. Deliberate self-harm. Measured on a 9-point likert scale that rated the frequency of self-harming behaviour over the previous year.<br> 5. Service Satisfaction Scale (SSS-30) was used to assess client satisfaction with the service, using a 5-point likert scale.<br><br> All were self-report measures and were measured before and after the study period, and at 12- and 24-month follow-up.<br>